Beijing Beilu Pharmaceutical Co (SZSE:300016) Total Liabilities : ¥1,070.6 Mil (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Beijing Beilu Pharmaceutical Co Total Liabilities?

Beijing Beilu Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥1,070.6 Mil.

Beijing Beilu Pharmaceutical Co's quarterly Total Liabilities increased from Sep. 2023 (¥985.58 Mil) to Dec. 2023 (¥1,033.11 Mil) and increased from Dec. 2023 (¥1,033.11 Mil) to Mar. 2024 (¥1,070.55 Mil).

Beijing Beilu Pharmaceutical Co's annual Total Liabilities increased from Dec. 2021 (¥818.22 Mil) to Dec. 2022 (¥895.39 Mil) and increased from Dec. 2022 (¥895.39 Mil) to Dec. 2023 (¥1,033.11 Mil).

Beijing Beilu Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Beijing Beilu Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Beilu Pharmaceutical Co Total Liabilities Chart

Beijing Beilu Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

173.31

955.50

818.22

895.39

1,033.11

Beijing Beilu Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															943.75	939.38	985.58	1,033.11	1,070.55

Beijing Beilu Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Beijing Beilu Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	359.17	+	(599.718	+	74.224
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,033.1

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	2819.424	-	1786.312
	=	1,033.1

Beijing Beilu Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	368.026	+	(629.641	+	72.885
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,070.6

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	2869.853	-	1799.301
	=	1,070.6

Beijing Beilu Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Beijing Beilu Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Beilu Pharmaceutical Co (SZSE:300016) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Beilu Pharmaceutical Co Ltd (SZSE:300016) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

No. 3, Shuiyuan West Road, Miyun District, Beijing, CHN, 100082

Website

http://www.beilu.com.cn

Beijing Beilu Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of pharmaceutical products. The products of the company are contrasted agent series, psychotropic, and hypoglycemic products which include iopamidol injection, iodixanol injection, and reglinide tablets.

Executives

Zong Li	Directors, executives
Hong Cheng Jie	Director
Duan Xian Zhu	Directors, executives
Zhu Zhi	Director
Wang Dai Xue	Director
Li Hong	Directors, executives
Liu Ning	Directors, executives
Wu Rui Hua	Directors, executives
Wu Jie	Executives
Liu Dong Long	Supervisors
Hong Wei	Directors, executives

Beijing Beilu Pharmaceutical Co (SZSE:300016) Headlines

No Headlines